chloroquine
At the 8 year       visit, 23%, 33%, and 2% of the Heinola patients, and 6%, 45%, and 21% of the       Jyvaskyla patients respectively were being treated with chloroquine, other single       DMARDs, or DMARD combinations.
At the 8 year       visit, 23%, 33%, and 2% of the Heinola patients, and 6%, 45%, and 21% of the       Jyvaskyla  @OBJECT$  respectively were being  @PREDICAT$  with  @SUBJECT$ , other single       DMARDs, or DMARD combinations.